N-(3,4-Dimethylphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide

Catalog No. :
ACSLTI022
CAS No. :
1775347-65-3
Molecular Formula :
C23H27N3O2
Molecular Weight :
377.49

IUPAC Name:N-(3,4-dimethylphenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide

N-(3,4-Dimethylphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$321.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(3,4-Dimethylphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide
IUPAC NameN-(3,4-dimethylphenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide
Molecular FormulaC23H27N3O2
Molecular Weight377.49
SMILESO=C(C1=CC(N(C)C2N3CCCCC2)=C(C=C1)C3=O)NC4=CC=C(C)C(C)=C4
InChI KeyRFTOBKHWUOYECK-UHFFFAOYSA-N
SynonymN-(3,4-dimethylphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide;Azepino[2,1-b]quinazoline-3-carboxamide, N-(3,4-dimethylphenyl)-5,5a,6,7,8,9,10,12-octahydro-5-methyl-12-oxo-
CAS No.1775347-65-3

Synthetic Route by SureRoute

1. ACSLTI022 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHCWT056 route compound structure diagram
    ACHCWT0567356-54-9 In Stock
  4. Then
  5. ACSLTI022 route product structure diagram
    ACSLTI0221775347-65-3
Inquiry

2. ACSLTI022 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHCWT056 route compound structure diagram
    ACHCWT0567356-54-9 In Stock
  4. Then
  5. ACSLTI022 route product structure diagram
    ACSLTI0221775347-65-3
Inquiry

Comments (0)